瑞财经 吴文婷2月25日，江苏鑫华半导体科技股份有限公司（以下简称"鑫华科技"）科创板IPO获受理。 本次IPO的保荐机构为招商证券股份有限公司，保荐代表人为姜博、吴宏兴，会计师事务所为毕马威华振会计师事务所（特殊普通合伙），律师事务所为北 京市竞天公诚律师事务所。 公司生产的电子级多晶硅是支撑整个半导体制造产业的关键基础材料，直接应用于半导体硅片与半导体用硅部件生产。 本次募集资金扣除发行费用后,将投资于以下项目: 单位:万元 | 序号 | 项目名称 | 总投资额 | 拟投入募集资金金额 | | --- | --- | --- | --- | | 1 | 10,000 吨/年高纯电子级多晶硅 产业集群项目 | 282,832.22 | 18,000.00 | | 2 | 1,500 吨/年超高纯多晶硅项目 | 40,025.46 | 24,000.00 | | 3 | 1,500 吨/年区熔用多晶硅项目 | 50,870.33 | 50,000.00 | | 4 | 高纯硅材料研发基地项目 | 20,388.05 | 20,000.00 | | ਦੇ | 补充流动资金 | 20,000.00 | 20,00 ...

Core Viewpoint - Anlu Technology, a semiconductor company, announced that several shareholders, including the National Integrated Circuit Industry Investment Fund, plan to reduce their holdings by up to 4% of the company's shares, with the National Fund intending to sell no more than 8.02 million shares, accounting for up to 2% of the total share capital [1][4]. Group 1: Shareholder Reduction Plans - The National Integrated Circuit Industry Investment Fund plans to reduce its holdings by up to 8.02 million shares, which is no more than 2% of the total share capital [1][4]. - Other shareholders, including Anxin Partnership, Anlu Chip Partnership, and Shenzhen Sixi, also plan to reduce their holdings by various amounts, with total reductions not exceeding 4% [2][6]. - The reduction period for these share sales will be within three months after 15 trading days from the announcement date [1][6]. Group 2: Company Performance Forecast - Anlu Technology forecasts its annual revenue for 2025 to be between 510 million yuan and 550 million yuan, representing a year-on-year decline of 15.62% to 21.76% [2][7]. - The company expects a net loss attributable to shareholders of between 280 million yuan and 230 million yuan for 2025, compared to a loss of 205 million yuan in the previous year [2][7]. - Despite a decline in revenue, the company anticipates a recovery starting in the second quarter of 2025, driven by a gradual resurgence in demand from downstream customers and the introduction of new products [3][7]. Group 3: Fundraising and Investment Plans - Anlu Technology announced a plan to raise up to 1.262 billion yuan through a private placement, with net proceeds intended for the development of advanced FPGA chip projects [3][7].

Core Insights - The recent announcements from the Shanghai Stock Exchange highlight significant movements in the semiconductor industry, particularly regarding the National Integrated Circuit Industry Investment Fund (National Big Fund) and its plans to reduce holdings in various companies, including Anlu Technology [1][2][3] Group 1: National Big Fund's Actions - Anlu Technology announced that shareholders, including the National Big Fund, plan to reduce their holdings by up to 4% of the total shares, with the National Big Fund specifically reducing up to 8.02 million shares, representing no more than 2% of total shares [1][2] - Other semiconductor companies, such as Hushi Industry and Huizhiwei, have also disclosed similar reduction plans, indicating a broader trend of the National Big Fund's divestment across the semiconductor sector [2][3] - The National Big Fund's recent actions are interpreted not merely as negative signals but as indicators of the maturation and confidence of China's semiconductor industry under national strategic capital [1][2] Group 2: Financial Performance and Future Outlook - Anlu Technology's 2025 performance forecast indicates a year-on-year revenue decline and continued net losses, although a recovery trend is noted from the second quarter onward [2] - Hushi Industry's announcement revealed a planned reduction of up to 3% of its total shares by the National Big Fund, following a previous reduction that raised approximately 1.26 billion yuan [2] - The National Big Fund's first phase, established in 2014, is now in a phase of investment recovery, having supported key companies in the semiconductor sector, which are now becoming self-sustaining and competitive [4][5] Group 3: Investment Strategy and Future Funds - The National Big Fund operates with a market-oriented approach, with its first phase focusing on chip manufacturing and the second phase targeting semiconductor equipment and materials [4][5] - The second and third phases of the National Big Fund are actively investing in strategic areas of the semiconductor industry, with the second phase entering a "dual investment and exit" phase while the third phase accelerates investments in core technologies [5][6]

Core Viewpoint - The National Integrated Circuit Industry Investment Fund (referred to as "National Big Fund") has been actively reducing its holdings in the semiconductor sector since the beginning of the year, which has drawn significant market attention [1] Group 1: Fund Reduction Activities - On February 8, Anlu Technology (688107.SH) announced that the Big Fund Phase I plans to reduce its holdings by no more than 2% of the company's total share capital within the next three months [1] - This marks the third time since 2025 that Anlu Technology has faced a reduction plan from the Big Fund [1] - Other semiconductor companies such as Hu Silicon Industry (688126.SH), Tailin Micro (688591.SH), and Huizhi Micro (688512.SH) have also recently disclosed the latest reduction progress or plans from the Big Fund [1] Group 2: Long-term Strategy - Despite the frequent short-term reduction activities, the industry generally views this as a normal exit behavior for an investment fund, indicating that the strategic direction of supporting domestic growth and facilitating domestic substitution remains unchanged [1]

开年以来，国家集成电路产业投资基金（下称"国家大基金"）在半导体板块的减持动作持续受到市场关 注。2月8日晚间，安路科技（688107.SH）发布公告称，股东大基金一期拟在未来三个月内减持不超过 公司总股本的2%。这已是安路科技自2025年以来第三次迎来大基金的减持计划。 与此同时，沪硅产业（688126.SH）、泰凌微（688591.SH）、慧智微（688512.SH）等多家半导体公司 也在近期相继披露了大基金的最新减持进展或计划。从已公布的信息来看，大基金一期、二期均有减持 操作，涉及公司多为已上市多年的半导体产业链企业。 尽管短期内减持动作频繁，但业内普遍认为，这是大基金作为产业投资基金的正常投资退出行为，长期 陪伴产业成长、助力国产替代的战略方向并未改变。 大基金多次减持安路科技、沪硅产业 在近期公告大基金减持计划或减持进展的半导体上市公司中，沪硅产业与安路科技都是在近半个月内迎 来二度减持。 截至公告日，大基金一期持有安路科技2295.45万股股份，占公司总股本的5.73%，均为IPO前取得。此 次减持计划显示，大基金拟在公告披露之日起15个交易日后的3个月内，通过集中竞价或大宗交易方式 减持不超过 ...

Core Insights - The semiconductor industry is experiencing significant movements from state-backed funds, particularly the National Integrated Circuit Industry Investment Fund, indicating a shift in investment strategy [1][4]. Group 1: National Fund's Share Reduction - Anlu Technology announced that the National Fund plans to reduce its stake by up to 802,000 shares, representing no more than 2% of the company's total shares [2]. - Other companies like Hu Silicon Industry, Wisdom Micro, and Tailin Micro have also disclosed share reductions by the National Fund, indicating a broader trend in the semiconductor sector [3]. Group 2: Financial Performance and Projections - Anlu Technology is facing financial challenges, with a projected net loss of 230 million to 280 million yuan for 2025, which is an increase compared to the previous year [2]. - Hu Silicon Industry anticipates a net loss of 1.28 billion to 1.53 billion yuan for 2025, reflecting the financial strain within the sector [3]. Group 3: Investment Strategy Shifts - The National Fund's first phase is entering a recovery period, leading to systematic exits from mature sectors while the third phase is actively investing in critical areas such as semiconductor equipment and materials [1][4]. - The third phase of the National Fund is focusing on upstream core segments of the semiconductor industry, demonstrating strong support for self-sufficiency in the semiconductor supply chain [7].

大基金，有新动作！ 2月8日晚间，半导体公司安路科技在上交所公告，公司股东国家集成电路产业投资基金（简称"国家大 基金"）、深圳思齐、士兰创投、士兰微等拟合计减持不超过4%公司股份。其中，国家大基金拟减持不 超802万股，占公司总股本的比例不超过2%。 此前，2月6日晚间，半导体企业沪硅产业公告，股东国家大基金拟减持不超过3%公司股份；同日晚 间，慧智微公告，大基金二期在1月12日至1月27日期间合计减持269万股，占公司总股本的0.575%；2 月3日晚间，泰凌微公告，国家大基金于2025年12月24日至2026年2月3日期间，通过集中竞价方式减持 公司股份232万股。 市场分析人士指出，国家大基金一期早已进入回收期，正加速减持退出成熟领域。大基金二期目前已进 入投退并举的阶段，在有序推进部分项目退出的同时，仍持续在半导体产业链的关键薄弱环节进行战略 性布局。而大基金三期正全面开展投资，加速投向半导体设备、材料等核心环节，持续支持集成电路产 业发展。 国家大基金拟减持安路科技 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 安路科技2月8日晚间，公司于近日收到股东国家大基金、安芯合伙、安路 ...

大基金，有新动作！ 2月8日晚间，半导体公司安路科技在上交所公告，公司股东国家集成电路产业投资基金（简称"国家大基 金"）、深圳思齐、士兰创投、士兰微等拟合计减持不超过4%公司股份。其中，国家大基金拟减持不超802万 股，占公司总股本的比例不超过2%。 此前，2月6日晚间，半导体企业沪硅产业公告，股东国家大基金拟减持不超过3%公司股份；同日晚间，慧智 微公告，大基金二期在1月12日至1月27日期间合计减持269万股，占公司总股本的0.575%；2月3日晚间，泰凌 微公告，国家大基金于2025年12月24日至2026年2月3日期间，通过集中竞价方式减持公司股份232万股。 市场分析人士指出，国家大基金一期早已进入回收期，正加速减持退出成熟领域。大基金二期目前已进入投退 并举的阶段，在有序推进部分项目退出的同时，仍持续在半导体产业链的关键薄弱环节进行战略性布局。而大 基金三期正全面开展投资，加速投向半导体设备、材料等核心环节，持续支持集成电路产业发展。 沪硅产业：国家大基金拟减持不超3%股份 2月6日晚间，沪硅产业公告，基于自身经营管理需要，国家大基金计划自公告披露之日起15个交易日后的3个 月内，通过大宗交易或 ...

Core Viewpoint - China National Academy of Sciences Shenyang Instrument Co., Ltd. (referred to as Zhongke Instrument) has successfully passed the listing review by the Beijing Stock Exchange, marking its entry into the capital market and highlighting significant breakthroughs in independent innovation in high-end vacuum equipment [1] Group 1: Company Overview - Founded in 1958, Zhongke Instrument focuses on clean vacuum and ultra-high vacuum technology, serving national strategic needs and industrial upgrades [1] - The company specializes in the research, production, and sales of dry vacuum pumps and vacuum scientific instruments, with core products widely used in semiconductor fields such as integrated circuit wafer manufacturing and photovoltaic battery production [1] - Zhongke Instrument is one of the few domestic companies capable of competing with international giants in the high-end vacuum equipment sector [1] Group 2: Technological Innovation - Technological innovation is the core competitive advantage of Zhongke Instrument, supported by three national-level R&D platforms [2] - The company has won six national science and technology progress awards and has undertaken 13 national-level major research projects, including tasks related to national information industry security [2] - As of June 30, 2025, Zhongke Instrument holds 100 invention patents and has led or participated in the formulation of 13 national and industry standards [2] Group 3: Market Performance - As of the reporting period, Zhongke Instrument has shipped over 40,000 dry vacuum pumps, with more than 30,000 units in the integrated circuit sector [3] - The company holds a 12.72% market share in the domestic dry vacuum pump market for integrated circuits, ranking first among domestic manufacturers [3] - Zhongke Instrument has established a customer network that includes major domestic players and has passed strict certifications from international semiconductor manufacturers [3] Group 4: Financial Performance - From 2022 to 2024, Zhongke Instrument's revenue increased from 698 million to 1.082 billion, with a compound annual growth rate of 24.51% [3] - The net profit attributable to the parent company grew from 61.86 million to 87.88 million, with a compound annual growth rate of 19.19% [3] - The company expects its total revenue for 2025 to reach between 1.241 billion and 1.281 billion, indicating strong growth momentum [3] Group 5: IPO and Funding - In its IPO, Zhongke Instrument aims to raise 825 million for projects including the industrialization of dry vacuum pumps and the expansion of high-end semiconductor equipment [4] - The company is backed by strong shareholders, including the controlling shareholder, which ensures continuous access to research resources and technological guidance [4] - The involvement of the National Integrated Circuit Industry Investment Fund provides valuable resources for industry chain integration and support for industrialization [4]

Core Viewpoint - The article emphasizes the importance of developing "patient capital" to support technological innovation and the transition to a modernized economy in China, as outlined in the Central Committee's decision on deepening reforms [1][2]. Group 1: Definition and Importance of Patient Capital - Patient capital refers to investments that prioritize long-term returns over short-term gains, focusing on projects with significant growth potential and resilience to market fluctuations [1]. - It is primarily sourced from government investment funds, pension funds, and insurance capital, providing stable funding for technological and industrial innovation [1][2]. Group 2: Role of Patient Capital in Technological Innovation - Technological innovation is crucial for developing new productive forces, but it often faces challenges such as high uncertainty and long funding cycles, making patient capital essential for supporting early-stage tech companies [2][3]. - Patient capital not only considers short-term financial returns but also evaluates non-financial indicators like technological innovation capabilities and business models, thus fostering long-term growth [2]. Group 3: Current Developments and Achievements - During the 14th Five-Year Plan period, significant progress has been made in nurturing patient capital, particularly in hard technology sectors, with the National Integrated Circuit Industry Investment Fund II focusing on critical areas like chip manufacturing [3]. - The Shenzhen government fund has mobilized nearly 500 billion yuan to support over 8,000 industrial projects, fostering more than 1,500 specialized enterprises and nearly 600 listed companies [3]. Group 4: Challenges Facing Patient Capital - There is an imbalance in the supply structure of patient capital, with excessive reliance on government funds and insufficient market-driven capital [4]. - The market ecosystem is underdeveloped, with limited exit channels and a lack of professional intermediary services, which dampens investment in high-risk early-stage projects [4]. Group 5: Recommendations for Future Development - To enhance patient capital, it is recommended to increase the investment ratio of pension and insurance funds in early-stage hard technology funds and provide tax incentives [5]. - Improving the market ecosystem through reforms in the Sci-Tech Innovation Board and developing a secondary market for private equity can enhance liquidity and reduce investment risks [5].